Prestige Wealth Management Group LLC Has $1.61 Million Stock Position in UnitedHealth Group Incorporated $UNH

Prestige Wealth Management Group LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 83.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,873 shares of the healthcare conglomerate’s stock after purchasing an additional 2,216 shares during the quarter. Prestige Wealth Management Group LLC’s holdings in UnitedHealth Group were worth $1,609,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of UNH. Norges Bank acquired a new position in UnitedHealth Group in the fourth quarter valued at about $4,376,167,000. Capital Research Global Investors raised its stake in UnitedHealth Group by 126.9% during the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock worth $4,503,419,000 after acquiring an additional 7,293,009 shares in the last quarter. Capital World Investors raised its stake in UnitedHealth Group by 18.8% during the third quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock worth $7,516,107,000 after acquiring an additional 3,439,182 shares in the last quarter. Capital International Investors raised its stake in UnitedHealth Group by 11.1% during the third quarter. Capital International Investors now owns 17,499,949 shares of the healthcare conglomerate’s stock worth $6,042,710,000 after acquiring an additional 1,747,337 shares in the last quarter. Finally, Lone Pine Capital LLC acquired a new position in UnitedHealth Group during the second quarter worth about $528,273,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on the company. Mizuho boosted their target price on UnitedHealth Group from $410.00 to $440.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 20th. Truist Financial boosted their target price on UnitedHealth Group from $395.00 to $440.00 and gave the stock a “buy” rating in a research note on Monday. Royal Bank Of Canada boosted their target price on UnitedHealth Group from $361.00 to $400.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. HC Wainwright set a $492.00 price target on UnitedHealth Group in a report on Wednesday, May 27th. Finally, HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price target on the stock in a report on Tuesday, April 7th. One research analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $404.42.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.28% of the stock is owned by insiders.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Bank of America upgraded UnitedHealth to Buy from Neutral and lifted its price target to $450, citing improving medical cost trends and a better risk/reward setup ahead of earnings. Article Title
• Positive Sentiment: Morgan Stanley also raised its price target on UNH to $453 and kept an Overweight rating, reinforcing the view that the stock has room to recover. Article Title
• Positive Sentiment: UnitedHealth raised its quarterly dividend by 5% to $2.32 per share, marking its 16th consecutive year of dividend increases and signaling confidence in cash flow despite a tough insurance backdrop. Article Title
• Positive Sentiment: Multiple market reports noted that analysts are increasingly optimistic on managed-care names, pointing to softer medical cost and utilization trends that could support earnings recovery for UNH. Article Title
• Neutral Sentiment: The company also provided updates on its annual shareholder meeting and board actions, with shareholders re-electing directors and approving executive compensation; these items are routine and do not appear to be the main driver of trading. Article Title
• Negative Sentiment: Broader market headlines show weakness in tech stocks and mixed futures, but these macro moves appear to be secondary to the strong company-specific buying in UNH today. Article Title

UnitedHealth Group Stock Performance

NYSE:UNH opened at $397.25 on Friday. The stock has a market cap of $360.76 billion, a P/E ratio of 30.00, a price-to-earnings-growth ratio of 1.62 and a beta of 0.64. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69. The stock’s 50-day moving average is $345.52 and its 200-day moving average is $323.05. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $404.15.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. During the same period in the prior year, the business posted $7.20 earnings per share. The firm’s revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 15th will be issued a $2.32 dividend. The ex-dividend date is Monday, June 15th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 annualized dividend and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 66.77%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.